<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0189111</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-44636</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Inflammatory bowel disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject><subj-group><subject>Endoscopy</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>C-reactive proteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Professions</subject><subj-group><subject>Medical personnel</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Physicians</subject><subj-group><subject>General practitioners</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care providers</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Physicians</subject><subj-group><subject>General practitioners</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Pediatric gastroenterology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pediatrics</subject><subj-group><subject>Pediatric gastroenterology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Primary care</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pediatrics</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care</article-title>
<alt-title alt-title-type="running-head">Diagnostic test strategies for inflammatory bowel disease</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Holtman</surname>
<given-names>Gea A.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lisman-van Leeuwen</surname>
<given-names>Yvonne</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kollen</surname>
<given-names>Boudewijn J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Norbruis</surname>
<given-names>Obbe F.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Escher</surname>
<given-names>Johanna C.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Walhout</surname>
<given-names>Laurence C.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kindermann</surname>
<given-names>Angelika</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>de Rijke</surname>
<given-names>Yolanda B.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>van Rheenen</surname>
<given-names>Patrick F.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Berger</surname>
<given-names>Marjolein Y.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Pediatrics, Isala Hospital, Zwolle, The Netherlands</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Pediatric Gastroenterology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Pediatric Gastroenterology, Emma Children’s Hospital ⁄ Academic Medical Center, Amsterdam, the Netherlands</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Clinical Chemistry, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Department of Pediatric Gastroenterology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Ro</surname>
<given-names>Seungil</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Nevada School of Medicine, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">g.a.holtman@umcg.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>6</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<elocation-id>e0189111</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Holtman et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0189111"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>In children with symptoms suggestive of inflammatory bowel disease (IBD) who present in primary care, the optimal test strategy for identifying those who require specialist care is unclear. We evaluated the following three test strategies to determine which was optimal for referring children with suspected IBD to specialist care: 1) alarm symptoms alone, 2) alarm symptoms plus c-reactive protein, and 3) alarm symptoms plus fecal calprotectin.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>A prospective cohort study was conducted, including children with chronic gastrointestinal symptoms referred to pediatric gastroenterology. Outcome was defined as IBD confirmed by endoscopy, or IBD ruled out by either endoscopy or unremarkable clinical 12 month follow-up with no indication for endoscopy. Test strategy probabilities were generated by logistic regression analyses and compared by area under the receiver operating characteristic curves (AUC) and decision curves.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>We included 90 children, of whom 17 (19%) had IBD (n = 65 from primary care physicians, n = 25 from general pediatricians). Adding fecal calprotectin to alarm symptoms increased the AUC significantly from 0.80 (0.67–0.92) to 0.97 (0.93–1.00), but adding c-reactive protein to alarm symptoms did not increase the AUC significantly (p &gt; 0.05). Decision curves confirmed these patterns, showing that alarm symptoms combined with fecal calprotectin produced the diagnostic test strategy with the highest net benefit at reasonable threshold probabilities.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>In primary care, when children are identified as being at high risk for IBD, adding fecal calprotectin testing to alarm symptoms was the optimal strategy for improving risk stratification.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003142</institution-id>
<institution>Fonds NutsOhra</institution>
</institution-wrap>
</funding-source>
<award-id>0802-099</award-id>
</award-group>
<award-group id="award002">
<funding-source>
<institution>University Medical Centre Groningen doelmatigheidsonderzoek</institution>
</funding-source>
<award-id>689 302</award-id>
</award-group>
<funding-statement>This study was funded by a grant from the Netherlands Fonds NutsOhra (grant number 0802-099) and a grant from the University Medical Centre Groningen doelmatigheidsonderzoek (grant number 689 302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="4"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Abdominal pain is a common gastrointestinal symptom in children that prompts a visit to the general practitioner [<xref ref-type="bibr" rid="pone.0189111.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0189111.ref003">3</xref>]. In most children, abdominal symptoms are attributed to functional gastrointestinal disorders (FGIDs), and in a few children to an organic disease [<xref ref-type="bibr" rid="pone.0189111.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0189111.ref006">6</xref>]. This distinction is important because children with FGIDs have no structural or biochemical abnormalities and can be managed in primary care [<xref ref-type="bibr" rid="pone.0189111.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0189111.ref008">8</xref>]; moreover, excessive testing can sustain complaints and decrease patient well-being [<xref ref-type="bibr" rid="pone.0189111.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0189111.ref010">10</xref>]. However, a thorough differential diagnosis is necessary to avoid delaying diagnosis and appropriate treatment of serious organic disease, such as inflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="pone.0189111.ref011">11</xref>].</p>
<p>Differentiation between FGID and IBD is difficult, however, because symptoms are non-specific and frequently overlap. The absence of alarm symptoms (e.g., weight loss and rectal blood loss) may help general practitioners to exclude IBD and prevent the unnecessary referral of children with FGIDs [<xref ref-type="bibr" rid="pone.0189111.ref012">12</xref>]. However, these alarm symptoms are common and are often related to illnesses that could be safely managed in primary care (e.g., rectal bleeding caused by anal fissuring related to constipation). The trade-off between the benefits (early recognition of IBD) and harms (referral of FGIDs) of referral and the lack of adequate tools to discriminate children with IBD, triggers general practitioners to either refer children with abdominal symptoms for further diagnostic work-up or perform non-valid tests [<xref ref-type="bibr" rid="pone.0189111.ref004">4</xref>].</p>
<p>In primary care, evaluating alarm symptoms and blood markers is the most commonly used diagnostic strategy for triaging children with chronic gastrointestinal symptoms before referral to specialist care [<xref ref-type="bibr" rid="pone.0189111.ref013">13</xref>]. C-reactive protein has shown the best diagnostic performance of blood markers, but evaluation of its diagnostic value is limited to highly selected children [<xref ref-type="bibr" rid="pone.0189111.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0189111.ref015">15</xref>]. More recently, fecal calprotectin has been shown to be a useful, simple, and non-invasive test that can exclude IBD in primary care [<xref ref-type="bibr" rid="pone.0189111.ref016">16</xref>]. Although test characteristics such as sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) have been presented, the added value of c-reactive protein, or fecal calprotectin to alarm symptoms are unknown [<xref ref-type="bibr" rid="pone.0189111.ref017">17</xref>]. In conclusion, there is little evidence to recommend additional testing in children with chronic gastrointestinal symptoms in primary care.</p>
<p>In this study, we aim to determine the optimal diagnostic test strategy supporting decisions for referral to specialist care in children with suspected IBD by evaluating the added diagnostic performance of c-reactive protein and fecal calprotectin beyond alarm symptoms. For that purpose, we compared three test strategies: 1) alarm symptoms alone, 2) alarm symptoms plus c-reactive protein, and 3) alarm symptoms plus fecal calprotectin.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec007">
<title>Setting and participants</title>
<p>We conducted a prospective cohort study between July 2011 and September 2014 in the Netherlands. All children were followed for 12 months. We recruited 2 cohorts of children with chronic gastrointestinal symptoms: 1) children initially seen in one out of 38 participating general practices (primary care cohort) and 2) children initially referred by either a general practitioner or general pediatrician to one of the participating medical centers (4 general hospitals and 3 academic centers) (referred cohort). Children included in the primary care cohort were also included in the referred cohort when they had ≥1 alarm symptom or an abnormal blood test (<xref ref-type="table" rid="pone.0189111.t001">Table 1</xref>), in accordance with the study protocol [<xref ref-type="bibr" rid="pone.0189111.ref018">18</xref>]. For this study we only included children in the referred cohort.</p>
<table-wrap id="pone.0189111.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.t001</object-id>
<label>Table 1</label> <caption><title>Diagnostic criteria for alarm symptoms, blood markers, and fecal calprotectin.</title></caption>
<alternatives>
<graphic id="pone.0189111.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Symptoms or tests</th>
<th align="center">Measurement</th>
<th align="center">Positive</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2"><bold>Alarm symptoms</bold></td>
<td align="left"/>
</tr>
<tr>
<td align="left">Rectal blood loss</td>
<td align="left">History</td>
<td align="left">Rectal bleeding with defecation without constipation according to ROME III criteria</td>
</tr>
<tr>
<td align="left">Family history of IBD</td>
<td align="left">History</td>
<td align="left">Affected first-degree relatives</td>
</tr>
<tr>
<td align="left">Involuntary weight loss</td>
<td align="left">History and physical examination</td>
<td align="left">Involuntary decrease in weight of &gt; 1 kg</td>
</tr>
<tr>
<td align="left">Growth failure</td>
<td align="left">History and physical examination</td>
<td align="left">Target height range more than −1 standard deviation score</td>
</tr>
<tr>
<td align="left">Extra-intestinal symptoms</td>
<td align="left">Physical examination</td>
<td align="left">Eyes (episcleritis, scleritis, uveitis), skin (erythema nodosum, pyoderma gangrenosum, psoriasis), mouth ulcers, finger clubbing, arthritis</td>
</tr>
<tr>
<td align="left">Peri-anal lesions</td>
<td align="left">Physical examination</td>
<td align="left">Skin tags, hemorrhoids, fissures, fistulas, and/or abscesses</td>
</tr>
<tr>
<td align="left"><bold>Blood markers</bold></td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Hemoglobin</td>
<td align="left">Local laboratory</td>
<td align="left">4–12 years &lt; 7.1 mmol/l,<break/>boys 12–18 years &lt; 8.1 mmol/l,<break/>girls 12–18 years &lt; 7.4 mmol/l [<xref ref-type="bibr" rid="pone.0189111.ref022">22</xref>]</td>
</tr>
<tr>
<td align="left">C-reactive protein</td>
<td align="left">Local laboratory</td>
<td align="left">&gt; 10 mg/l [<xref ref-type="bibr" rid="pone.0189111.ref023">23</xref>]</td>
</tr>
<tr>
<td align="left">Erythrocyte sedimentation rate</td>
<td align="left">Local laboratory</td>
<td align="left">&gt; 20 mm/h [<xref ref-type="bibr" rid="pone.0189111.ref023">23</xref>]</td>
</tr>
<tr>
<td align="left">platelet count</td>
<td align="left">Local laboratory</td>
<td align="left">&gt; 450 × 10<sup>9</sup>/l [<xref ref-type="bibr" rid="pone.0189111.ref024">24</xref>]</td>
</tr>
<tr>
<td align="left"><bold>Fecal marker</bold></td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Fecal calprotectin</td>
<td align="left">ELISA (Phical test)</td>
<td align="left">&gt; 50 μg/g</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Abbreviations: ELISA: enzyme-linked immunosorbent assay; IBD: inflammatory bowel disease.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>For inclusion, children had to be aged 4–18 years and presenting with chronic diarrhea (soft or watery stool, matching scores 5–7 of the Bristol Stool chart, for ≥2 weeks or ≥2 episodes in the past 6 months) [<xref ref-type="bibr" rid="pone.0189111.ref019">19</xref>] or recurrent abdominal pain or discomfort (≥2 episodes in the past 6 months) [<xref ref-type="bibr" rid="pone.0189111.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0189111.ref013">13</xref>]. An episode was defined as symptoms during three days or more. Participants were excluded if they had a known diagnosis of chronic organic gastrointestinal disease, had undergone endoscopic evaluation or fecal calprotectin measurement within the preceding 6 months, or had cognitive impairment or language problems that caused difficulty in understanding questionnaires. Furthermore, we excluded children with chronic use (&gt;3 months) of antibiotics, non-steroid anti-inflammatory drugs (NSAID), or oral corticosteroids, as well as children aged under 4 years, because the calprotectin levels of these groups have been shown to be higher than those observed in healthy older children and adults [<xref ref-type="bibr" rid="pone.0189111.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0189111.ref021">21</xref>].</p>
<p>The Medical Ethics Committee of the University Medical Centre Groningen, the Netherlands, approved the study. Parents of all children provided written informed consent, as did children aged 12 years or older.</p>
</sec>
<sec id="sec008">
<title>Baseline measurements</title>
<p>At baseline, the general practitioner or pediatrician performed a structured physical examination to identify the six alarm symptoms, using a standardized form [<xref ref-type="bibr" rid="pone.0189111.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0189111.ref013">13</xref>]. A blood sample was taken from all patients to measure four blood markers at local laboratories (c-reactive protein, hemoglobin, erythrocyte sedimentation rate, and platelet count). Directly after baseline, all children collected a stool sample that was sent to a laboratory for storage at –80°C. At the end of the data collection period (September 2014), calprotectin was measured in the department of clinical chemistry at Erasmus MC Rotterdam, using a commercially available quantitative enzyme-linked immunosorbent assay (Phical test, CALPRO AS, Oslo, Norway). Alarm symptoms and the thresholds for blood markers and fecal calprotectin are presented in <xref ref-type="table" rid="pone.0189111.t001">Table 1</xref>. All physicians, researchers, and patients were blinded to the outcome of the fecal calprotectin test, but not to the results of alarm symptoms or blood analyses. The technicians in all laboratories were blinded to the clinical characteristics and diagnoses of patients.</p>
</sec>
<sec id="sec009">
<title>Patient flow</title>
<p>After baseline assessment, a pediatric gastroenterologist decided whether to perform an endoscopy or not, based on interpretation of baseline findings and examination of the child. All children were followed for 12 months, and every 3 months a symptom questionnaire was completed by parent or child (if aged ≥10 years). The symptom questionnaire was developed in cooperation with experienced pediatric gastroenterologists and general practitioners (<xref ref-type="supplementary-material" rid="pone.0189111.s001">S1 Text</xref>. Children’s symptom questionnaire). At 12 months, either the general practitioner or pediatrician performed a structured physical examination of all children who still had chronic gastrointestinal symptoms and who had not received a diagnosis of IBD during the study. Children with at least one alarm symptom at this examination were seen again by the pediatric gastroenterologist who evaluated the need for endoscopy. If a child was lost to follow-up, the general practitioner or pediatrician was contacted to provide updated information on relevant diagnoses (IBD or other organic diseases) during the 12 months after baseline.</p>
</sec>
<sec id="sec010">
<title>Outcome</title>
<p>The diagnosis of IBD was confirmed by esophagogastroduodenoscopy and ileocolonoscopy, with histology, according to the Porto criteria [<xref ref-type="bibr" rid="pone.0189111.ref012">12</xref>]. Absence of IBD was defined as no endoscopic and histopathologic evidence of IBD or no indication for endoscopy within or at 12 months’ follow-up. Endoscopy was not considered to be indicated if there were no alarm symptoms for IBD or if the pediatric gastroenterologist considered that the identified alarm symptoms were not related to IBD.</p>
</sec>
<sec id="sec011">
<title>Statistical analyses</title>
<p>We calculated the test characteristics of alarm symptoms, blood markers and fecal calprotectin with 95% confidence intervals (CIs). In addition, we calculated the AUC for blood markers and fecal calprotectin.</p>
<p>We used logistic regression analysis to construct a basic model predicting the presence of IBD. The dependent variable was the IBD diagnosis (dichotomous). For the independent variable, we totaled the alarm symptoms into one variable (continuous) to comply with the number of events per variable (EPV) rule for obtaining adequate statistical power [<xref ref-type="bibr" rid="pone.0189111.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0189111.ref026">26</xref>]. We added weighting scores to the alarm symptoms, because the symptoms are known to have different predictive values [<xref ref-type="bibr" rid="pone.0189111.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0189111.ref013">13</xref>].</p>
<p>To evaluate the added value of c-reactive protein and fecal calprotectin (both continuous scaled) to alarm symptoms alone (basic model), the variables were added to the basic model and their probabilities were compared to those of the basic model by calculating differences between AUCs, using the method described by DeLong [<xref ref-type="bibr" rid="pone.0189111.ref027">27</xref>]. The models were also assessed with goodness-of-fit tests and calibration plots.</p>
<p>We used decision curve analysis to evaluate the clinical usefulness of decision-making based on the three diagnostic strategies [<xref ref-type="bibr" rid="pone.0189111.ref028">28</xref>–<xref ref-type="bibr" rid="pone.0189111.ref030">30</xref>]. We chose a range of threshold probabilities with an upper limit of 40%, because it is unrealistic that any general practitioner would accept more than a 40% risk of IBD for a referral to be justified [<xref ref-type="bibr" rid="pone.0189111.ref017">17</xref>]. Strategies with the highest net benefit at a particular threshold were considered preferable to alternative strategies.</p>
<p>To evaluate the verification pattern of which children received endoscopy at baseline, we compared baseline characteristics and risk of IBD in children with and without endoscopy at baseline. We expected that especially children at high risk would be subjected to an endoscopy.</p>
<p>If the distribution between variables in patients with and without missing data was different, the data were considered missing at random (MAR) [<xref ref-type="bibr" rid="pone.0189111.ref031">31</xref>]. In that case, we conducted multiple imputations (fully conditional specification, predictive mean matching, [<xref ref-type="bibr" rid="pone.0189111.ref032">32</xref>] 20 iterations, 20 datasets), using patient characteristics, symptoms, tests and outcome as predictors [<xref ref-type="bibr" rid="pone.0189111.ref033">33</xref>]. We used Rubin’s rule to calculate the pooled AUC [<xref ref-type="bibr" rid="pone.0189111.ref034">34</xref>]. We presented results of the non-imputed (complete case analysis) and imputed dataset. Statistical analyses were performed with IBM SPSS, Version 24 (IBM corp., Armonk, New York, USA) and STATA/SE 13 (STATA Corp, College station, TX, USA).</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Participants</title>
<p><xref ref-type="fig" rid="pone.0189111.g001">Fig 1</xref> summarizes the patient flow in this study. Children referred to the pediatric gastroenterologist by a general pediatrician (n = 25) were older, more frequently had alarm symptoms, and were more likely to have IBD compared with children who were referred by a general practitioner (n = 65). Children who were subject to endoscopy at baseline (n = 25) more frequently had alarm symptoms, positive laboratory markers, and a high risk for IBD compared with children who underwent no endoscopy at baseline (n = 65) (<xref ref-type="table" rid="pone.0189111.t002">Table 2</xref>).</p>
<fig id="pone.0189111.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Patient flow diagram.</title>
<p>Abbreviations: IBD: inflammatory bowel disease.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0189111.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.t002</object-id>
<label>Table 2</label> <caption><title>Baseline characteristics of children by referrer and whether endoscopy was performed at baseline.</title></caption>
<alternatives>
<graphic id="pone.0189111.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">Referred by general practitioners<break/>(n = 65)</th>
<th align="center">Referred by general pediatrician<break/>(n = 25)</th>
<th align="center">No endoscopy At baseline<break/>(n = 65)</th>
<th align="center">Endoscopy At baseline<break/>(n = 25)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Male sex (n (%))</td>
<td align="center">29 (45)</td>
<td align="center">8 (32)</td>
<td align="center">27 (42)</td>
<td align="center">10 (40)</td>
</tr>
<tr>
<td align="left">Age in years at baseline (median, IQR)</td>
<td align="center">10 (7–14)</td>
<td align="center">14 (10–15.5)</td>
<td align="center">9 (6–14)</td>
<td align="center">15 (12–16)</td>
</tr>
<tr>
<td align="left"><bold>Duration symptoms (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left"> &lt;0.5 year</td>
<td align="center">14 (22)</td>
<td align="center">6 (24)</td>
<td align="center">12 (19)</td>
<td align="center">8 (32)</td>
</tr>
<tr>
<td align="left"> &gt;1 year</td>
<td align="center">41 (63)</td>
<td align="center">9 (36)</td>
<td align="center">42 (65)</td>
<td align="center">8 (32)</td>
</tr>
<tr>
<td align="left"><bold>History and physical examination (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">Growth failure</td>
<td align="center">6 (9.2)</td>
<td align="center">0 (0)</td>
<td align="center">5 (8)</td>
<td align="center">1 (4)</td>
</tr>
<tr>
<td align="left">Involuntary weight loss</td>
<td align="center">10 (15)</td>
<td align="center">13 (52)</td>
<td align="center">10 (15)</td>
<td align="center">13 (52)</td>
</tr>
<tr>
<td align="left">Rectal blood loss</td>
<td align="center">13 (20)</td>
<td align="center">14 (56)</td>
<td align="center">16 (25)</td>
<td align="center">11 (44)</td>
</tr>
<tr>
<td align="left">Positive family history of IBD</td>
<td align="center">9/64 (14)</td>
<td align="center">2 (8)</td>
<td align="center">6/64 (9)</td>
<td align="center">5 (20)</td>
</tr>
<tr>
<td align="left">Extra-intestinal symptoms</td>
<td align="center">4 (6)</td>
<td align="center">9 (36)</td>
<td align="center">6 (9)</td>
<td align="center">7 (28)</td>
</tr>
<tr>
<td align="left">Peri-anal lesions</td>
<td align="center">9 (14)</td>
<td align="center">4/24 (17)</td>
<td align="center">7 (11)</td>
<td align="center">6/24 (25)</td>
</tr>
<tr>
<td align="left">≥1 alarm symptoms</td>
<td align="center">38 (59)</td>
<td align="center">24 (96)</td>
<td align="center">39 (60)</td>
<td align="center">23 (92)</td>
</tr>
<tr>
<td align="left"><bold>Blood markers (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">hemoglobin (cut-off is age/sex specific<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref>)</td>
<td align="center">5/61 (8)</td>
<td align="center">6/24 (25)</td>
<td align="center">4/61 (7)</td>
<td align="center">7/24 (29)</td>
</tr>
<tr>
<td align="left">C-reactive protein (&gt;10 mg/l)</td>
<td align="center">5/56 (9)</td>
<td align="center">5/19 (26)</td>
<td align="center">2/53 (4)</td>
<td align="center">8/22 (36)</td>
</tr>
<tr>
<td align="left">erythrocyte sedimentation rate (&gt;20 mm/h)</td>
<td align="center">8/59 (14)</td>
<td align="center">8/24 (33)</td>
<td align="center">4/59 (7)</td>
<td align="center">12/24 (50)</td>
</tr>
<tr>
<td align="left">Platelet count (&gt;450 x10<sup>9</sup>/l)</td>
<td align="center">4/61 (7)</td>
<td align="center">3/24 (13)</td>
<td align="center">4/61 (7)</td>
<td align="center">3/24 (13)</td>
</tr>
<tr>
<td align="left">≥1 blood marker</td>
<td align="center">14/53 (28)</td>
<td align="center">10/19 (53)</td>
<td align="center">11/50 (22)</td>
<td align="center">13/22 (59)</td>
</tr>
<tr>
<td align="left"><bold>Fecal test (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">fecal calprotectin (&gt;50 μg/g)</td>
<td align="center">14/63 (22)</td>
<td align="center">13/22 (59)</td>
<td align="center">9/63 (14)</td>
<td align="center">18/22 (82)</td>
</tr>
<tr>
<td align="left"><bold>Reference standard (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">endoscopy</td>
<td align="center">9 (14)</td>
<td align="center">20 (80)</td>
<td align="center">4 (6)</td>
<td align="center">25 (100)</td>
</tr>
<tr>
<td align="left"><bold>Diagnoses (n (%))</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">IBD</td>
<td align="center">5 (8)</td>
<td align="center">12 (48)</td>
<td align="center">2 (3)</td>
<td align="center">15 (60)</td>
</tr>
<tr>
<td align="left">FGIDs<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td>
<td align="center">55 (85)</td>
<td align="center">11 (44)</td>
<td align="center">58 (89)</td>
<td align="center">8 (32)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p><sup>a</sup> 4–12 years &lt; 7.1 mmol/l, boys 12–18 years &lt; 8.1 mmol/l, girls 12–18 years &lt; 7.4 mmol/l.</p></fn>
<fn id="t002fn002"><p><sup>b</sup> Diagnosis of FGID was reached when after 12 months there were no signs of any inflammatory, anatomic, metabolic, or neoplastic pathology after thorough history, physical examination, and additional testing by the treating physician.</p></fn>
<fn id="t002fn003"><p>Abbreviations: FGID: functional gastrointestinal disorder; IBD: inflammatory bowel disease.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Diagnoses</title>
<p>IBD was confirmed in 17 patients (19%), of whom 7 had Crohn’s disease, 8 had ulcerative colitis, and 2 had unclassified IBD. Of the 72 children (80%) with other diagnoses, 66 (73%) had a FGID, 3 (3%) had gastroenteritis (<italic>salmonella enteric</italic> [n = 2]; <italic>Giardia lamblia</italic> [n = 1]), 1 (1%) had reflux esophagitis, 1 (1%) had celiac disease, and 1 (1%) had a solitary rectal ulcer. In one patient, the diagnosis was not known because the child, who was aged 16 years, refused endoscopic evaluation at baseline and evaluation by a general practitioner at 12 months.</p>
</sec>
<sec id="sec015">
<title>Test characteristics</title>
<p>All tests were performed before endoscopy. The median time intervals between blood sampling and endoscopy were 34 and 69 days for children with and without IBD, respectively. The median time interval between stool sampling and endoscopy was 4 days for children with IBD and was 8 days for children without IBD. Of the 29 children who underwent endoscopy, 11 (2 missing) had a delay of more than one month. Overall, 25 children had missing data for one or more variable of interest. The children with and without missing data were comparable in all baseline characteristics, except for extra-intestinal symptoms and setting (<xref ref-type="supplementary-material" rid="pone.0189111.s002">S1 Table</xref>). To reduce the probability of selection bias, we imputed the missing data [<xref ref-type="bibr" rid="pone.0189111.ref031">31</xref>]. The results of the non-imputed and imputed dataset were similar (<xref ref-type="table" rid="pone.0189111.t003">Table 3</xref>), therefore bias is less probable and we presented the results of the non-imputed dataset in the text.</p>
<table-wrap id="pone.0189111.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.t003</object-id>
<label>Table 3</label> <caption><title>The various diagnostic models for IBD with the non-imputed and imputed datasets.</title></caption>
<alternatives>
<graphic id="pone.0189111.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">Non-imputed<break/>DOR<break/>(95% CI)</th>
<th align="center">Imputed<break/>Pooled DOR<break/>(95% CI)</th>
<th align="center">Non-imputed<break/>AUC<break/>(95% CI)</th>
<th align="center">Imputed<break/>Pooled AUC<break/>(95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Alarm symptoms</td>
<td align="center">1.02 (1.01–1.04)</td>
<td align="center">1.02 (1.01–1.04)</td>
<td align="center">0.80 (0.67–0.92)</td>
<td align="center">0.80 (0.69–0.90)</td>
</tr>
<tr>
<td align="left" rowspan="2">Alarm symptoms + c-reactive protein</td>
<td align="center">1.02 (1.01–1.04)</td>
<td align="center">1.02 (1.01–1.03)</td>
<td align="center" rowspan="2">0.88(0.78–0.98)</td>
<td align="center" rowspan="2">0.85(0.76–0.93)</td>
</tr>
<tr>
<td align="center">1.18 (1.04–1.33)</td>
<td align="center">1.14 (1.01–1.27)</td>
</tr>
<tr>
<td align="left" rowspan="2">Alarm symptoms + fecal calprotectin</td>
<td align="center">1.01 (0.99–1.04)</td>
<td align="center">1.02 (0.99–1.04)</td>
<td align="center" rowspan="2">0.97(0.93–1.00)</td>
<td align="center" rowspan="2">0.97(0.93–1.00)</td>
</tr>
<tr>
<td align="center">1.01 (1.003–1.02)</td>
<td align="center">1.01 (1.003–1.03)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Basic model consisted of the number of weighted alarm symptoms (Total score: 357): growth failure (weight: 51), involuntary weight loss (weight: 44), rectal blood loss (weight: 60), family history of IBD (weight: 53), extra-intestinal symptoms (weight: 78), peri-anal lesions (weight: 71). The mean weighting scores for the alarm symptoms were based on the independent opinions of 85 physicians who treat children with chronic gastrointestinal symptoms in different clinical settings. The physicians weighted the alarm symptoms using a visual analog scale from 0 (completely excludes that the child has IBD) to 100 (absolutely confirms that the child has IBD). Interpretation DOR: one point increase on a continuous scaled test result (weighted alarm symptoms, c-reactive protein, fecal calprotectin) increases the risk of IBD with the DOR-value. Abbreviations: DOR: Diagnostic Odds Ratio; AUC: area under the curve.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The diagnostic characteristics of alarm symptoms, blood markers, and fecal calprotectin are shown in <xref ref-type="supplementary-material" rid="pone.0189111.s003">S2 Table</xref>. The AUC of fecal calprotectin was 0.98 (0.96–1.00), which was significantly higher than that for all blood markers individually (p &lt; 0.05).</p>
</sec>
<sec id="sec016">
<title>Added value of C-reactive protein and fecal calprotectin</title>
<p>The AUC of the basic model was 0.80 (0.67–0.92). Adding c-reactive protein or fecal calprotectin to the model increased the AUC to 0.88 (0.78–0.98) and 0.97 (0.93–1.00), respectively. However, this increase was only significant for fecal calprotectin (p &lt; 0.05) (<xref ref-type="table" rid="pone.0189111.t003">Table 3</xref>). The goodness-of-fit test was good for all models (Hosmer and Lemeshow test, p &gt; 0.05). The calibration plots of all models displayed linear concordance between the observed and predicted probabilities of IBD.</p>
</sec>
<sec id="sec017">
<title>Decision curve analysis</title>
<p>The decision curve analysis indicates that all three diagnostic strategies had higher net benefit at diagnostic threshold probabilities &gt;5% when compared with the alternative of referring all children (<xref ref-type="fig" rid="pone.0189111.g002">Fig 2</xref>). Alarm symptoms in combination with fecal calprotectin had the highest net benefit at threshold probabilities between 5% and 40%. <xref ref-type="table" rid="pone.0189111.t004">Table 4</xref> shows that the test strategy of alarm symptoms plus fecal calprotectin generated a higher reduction in the numbers of referrals without missing a child with IBD at different threshold probabilities compared to all other strategies.</p>
<fig id="pone.0189111.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Decision curve for the three models predicting the outcome of IBD in the non-imputed dataset.</title>
<p>Representative interpretation of the decision curve: the purple line representing the alarm symptoms + fecal calprotectin strategy shows a net benefit of 0.16 at a threshold probability of 20%. In this instance, a threshold probability of 20% means that a general practitioner would be willing to refer 5 children to prevent a delay in diagnosis for 1 child with IBD. The net benefit of 0.16 means that this strategy would lead to the referral of 160 per 1000 children at risk, with all referrals having IBD. Abbreviations: CRP: C-reactive protein, FCal: fecal calprotectin.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0189111.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0189111.t004</object-id>
<label>Table 4</label> <caption><title>Reduction in referral rate for further diagnostic work-up per 100 children using different threshold probabilities for the three test strategies.</title></caption>
<alternatives>
<graphic id="pone.0189111.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Threshold probability</th>
<th align="center">Alarm symptoms</th>
<th align="center">Alarm symptoms + c-reactive protein</th>
<th align="center">Alarm symptoms + fecal calprotectin</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">10%</td>
<td align="center">–</td>
<td align="center">15</td>
<td align="center">32</td>
</tr>
<tr>
<td align="left">15%</td>
<td align="center">12</td>
<td align="center">33</td>
<td align="center">49</td>
</tr>
<tr>
<td align="left">20%</td>
<td align="center">35</td>
<td align="center">40</td>
<td align="center">59</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>Note: The reduction in the number of referral for further diagnostic work-up per 100 children without missing a child with IBD was calculated as follows: (net benefit strategy—net benefit of refer all) / [P<sub>t</sub> / (1 –P<sub>t</sub>)] × 100.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Discussion</title>
<p>In this study, 73% of children referred for evaluation of chronic gastrointestinal symptoms had FGIDs that could be managed in primary care, and the prevalence of IBD was 19%. Interestingly, for children in whom general practitioners considered a referral for further diagnostic work-up, c-reactive protein provided no additional diagnostic value when used in combination with alarm symptoms. By contrast, the addition of fecal calprotectin to alarm symptoms significantly improved the AUC. Compared to the strategy of adding c-reactive protein to alarm symptoms, adding fecal calprotectin to alarm symptoms showed the highest net benefit and produced the greatest reduction in the number of referrals for IBD without any false negatives.</p>
<p>In clinical practice, physicians use diagnostic threshold probabilities to determine when they need to initiate further testing before deciding on further management. The decision curve analysis in this study indicated, that in children with a threshold probability of IBD that was &lt; 5%, testing with c-reactive protein or fecal calprotectin had limited additional value. Therefore, we advise against testing c-reactive protein or fecal calprotectin in children with a very low risk for IBD (e.g. without alarm symptoms). At threshold probabilities between 5% and 40%, however, the test strategy with alarm symptoms and fecal calprotectin showed highest net benefit. Moreover, the discriminative power of fecal calprotectin proved to be superior to all blood markers when compared individually. Therefore, on the bases of our results, we conclude that fecal calprotectin is the best laboratory test for use when seeking to further stratify children identified as at risk for IBD by history and physical examination. In our previous study in primary care, we showed that a calprotectin value below 50 μg/g feces can safely exclude IBD [<xref ref-type="bibr" rid="pone.0189111.ref016">16</xref>]. Therefore, a normal calprotectin value is a very reassuring test result that complements a thorough history and physical examination in children with chronic gastrointestinal symptoms. It is important that the GP is aware of factors that increase the fecal calprotectin value: the calprotectin value is increased in children with bacterial gastroenteritis, younger than four years, or using NSAIDs or antibiotics [<xref ref-type="bibr" rid="pone.0189111.ref021">21</xref>].</p>
<p>There are few publications about the added value for fecal calprotectin in children with symptoms suggestive of IBD. A study evaluating the added value of fecal calprotectin using the “clinical eye” of the pediatrician showed that fecal calprotectin reduced the need for referral to a pediatric gastroenterologist, with only a low risk of missing a child with IBD [<xref ref-type="bibr" rid="pone.0189111.ref023">23</xref>]. However, we could not determine how this approach incorporated alarm symptoms and blood markers. Other researchers constructed a model to predict the risk of having IBD based on fecal calprotectin and age,[<xref ref-type="bibr" rid="pone.0189111.ref035">35</xref>] and correctly identified 85.5% of children with a sensitivity of 0.81 and specificity of 0.92 (AUC 0.92). However, important predictors, such as alarm symptoms and blood markers, were not included in their model.</p>
<p>It is important to realize that our study included patients referred by general practitioners and general pediatricians. Although it was assumed that these represent the same patient population, the children referred by a pediatrician were more likely to have IBD, were older, and had more alarm symptoms compared with children referred by their general practitioner. This result is to be expected in the Dutch healthcare system, because pediatricians can only be consulted if patients are referred by a general practitioner, but pediatric gastroenterologists can be consulted if children are referred by either a general practitioner or a general pediatrician. Healthcare systems in the United Kingdom, Scandinavia, Canada, New Zealand, and Australia are similar [<xref ref-type="bibr" rid="pone.0189111.ref036">36</xref>].</p>
<p>A limitation of our study is that alarm symptoms are routinely assessed with blood markers in children with symptoms suggestive of IBD. Consequently, the reference standard was interpreted with prior knowledge of the test results of alarm symptoms and blood markers, which might have caused review bias and overestimation of the diagnostic accuracy of the alarm symptoms and blood markers [<xref ref-type="bibr" rid="pone.0189111.ref037">37</xref>]. Another limitation is that we did not perform endoscopies in children with a low likelihood of IBD, because this was considered unethical. There are two important aspects to consider when assessing whether the use of two reference standards lead to biased accuracy estimates: the verification pattern and the appropriateness of the follow-up [<xref ref-type="bibr" rid="pone.0189111.ref038">38</xref>]. Although the verification pattern was based on the clinical judgment of the pediatric gastroenterologist, and was thereby somewhat subjective, our results did show that children who received endoscopy at baseline were at higher risk for IBD than children who received follow-up. Therefore, if the test strategies were only evaluated in the children who received endoscopy at baseline, the results would probably be biased [<xref ref-type="bibr" rid="pone.0189111.ref039">39</xref>]. Although IBD is not a self-limiting disease and it is very rare for it to stay in remission for one year,[<xref ref-type="bibr" rid="pone.0189111.ref023">23</xref>] there is a very small chance that we missed a child with IBD; such data could alter the diagnostic values reported for the tests. However, follow-up is the best achievable option given the reality of clinical care [<xref ref-type="bibr" rid="pone.0189111.ref040">40</xref>].</p>
<p>Given that there were few children with IBD in our study (n = 17), we combined the weighted alarm symptoms into one variable based on the subjective opinions of 85 physicians. Despite this, the AUC of the combined alarm symptoms without weighting was comparable to that with weighting. We also evaluated the added value of two important markers based on eight events per variable; although it is recommend to have at least 10 events per variable it has been shown that 5 events per variable is appropriate [<xref ref-type="bibr" rid="pone.0189111.ref025">25</xref>]. A larger study with more events is needed for the development of a prediction model for IBD based on single alarm symptoms, blood markers, and fecal calprotectin results [<xref ref-type="bibr" rid="pone.0189111.ref029">29</xref>]. Moreover, an exploration of whether age influences the prediction model is needed.</p>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Conclusions</title>
<p>The addition of fecal calprotectin to an evaluation of alarm symptoms was the optimal strategy for stratifying children identified as being at risk of IBD by their general practitioner. This strategy is different to that published in several guidelines, which recommend testing for c-reactive protein and other blood markers of inflammation when alarm symptoms are present [<xref ref-type="bibr" rid="pone.0189111.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0189111.ref041">41</xref>]. It should be noted that we focused on IBD alone in this study, whereas general practitioners must evaluate whether symptoms are related to any organic disease, including celiac disease. Further studies are therefore needed to investigate whether the new test strategy combining the assessment of alarm symptoms with testing for fecal calprotectin can improve decision-making in clinical practice. These studies should also include a cost–benefit analysis.</p>
</sec>
<sec id="sec020">
<title>Supporting information</title>
<supplementary-material id="pone.0189111.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.s001" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>Children’s symptom questionnaire.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0189111.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.s002" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Complete data, number missing per variable, and difference in distribution between children with and without missing data.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0189111.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0189111.s003" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Diagnostic characteristics of alarm symptoms, blood markers, and fecal calprotectin for IBD with a pre-test probability of 19%, using the imputed dataset.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank the general practitioners and pediatricians involved in this study for recruiting patients, and we thank all participants for their contribution. The analytical support of Sascha Smit, Erasmus MC, was highly appreciated. We thank Dr Robert Sykes (<ext-link ext-link-type="uri" xlink:href="http://www.doctored.org.uk" xlink:type="simple">www.doctored.org.uk</ext-link>) for his editorial assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0189111.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peery</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Dellon</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Lund</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Crockett</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>McGowan</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Bulsiewicz</surname> <given-names>WJ</given-names></name>, <etal>et al</etal>. <article-title>Burden of gastrointestinal disease in the United States: 2012 update</article-title>. <source>Gastroenterology</source> <year>2012</year>;<volume>143</volume>(<issue>5</issue>):<fpage>1179</fpage>–<lpage>1187.e3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2012.08.002" xlink:type="simple">10.1053/j.gastro.2012.08.002</ext-link></comment> <object-id pub-id-type="pmid">22885331</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gieteling</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Lisman-van Leeuwen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>van der Wouden</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Schellevis</surname> <given-names>FG</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>MY</given-names></name>. <article-title>Childhood nonspecific abdominal pain in family practice: incidence, associated factors, and management</article-title>. <source>Ann Fam Med</source> <year>2011</year> <month>Jul-Aug</month>;<volume>9</volume>(<issue>4</issue>):<fpage>337</fpage>–<lpage>343</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1370/afm.1268" xlink:type="simple">10.1370/afm.1268</ext-link></comment> <object-id pub-id-type="pmid">21747105</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>BEACH Program</collab>, <collab>AIHW General Practice Statistics and Classification Unit</collab>. <article-title>Presentations of abdominal pain in Australian general practice</article-title>. <source>Aust Fam Physician</source> <year>2004</year> <month>Dec</month>;<volume>33</volume>(<issue>12</issue>):<fpage>968</fpage>–<lpage>969</lpage>. <object-id pub-id-type="pmid">15630915</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spee</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Lisman-Van Leeuwen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Benninga</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Bierma-Zeinstra</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>MY</given-names></name>. <article-title>Prevalence, characteristics, and management of childhood functional abdominal pain in general practice</article-title>. <source>Scand J Prim Health Care</source> <year>2013</year>;<volume>31</volume>(<issue>4</issue>):<fpage>197</fpage>–<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/02813432.2013.844405" xlink:type="simple">10.3109/02813432.2013.844405</ext-link></comment> <object-id pub-id-type="pmid">24106821</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kokkonen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Haapalahti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tikkanen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Karttunen</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Savilahti</surname> <given-names>E</given-names></name>. <article-title>Gastrointestinal complaints and diagnosis in children: a population-based study</article-title>. <source>Acta Paediatrica</source> <year>2004</year>;<volume>93</volume>(<issue>7</issue>):<fpage>880</fpage>–<lpage>886</lpage>. <object-id pub-id-type="pmid">15303801</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miele</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Simeone</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Marino</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Greco</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Auricchio</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Novek</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>Functional gastrointestinal disorders in children: an Italian prospective survey</article-title>. <source>Pediatrics</source> <year>2004</year> <month>Jul</month>;<volume>114</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>78</lpage>. <object-id pub-id-type="pmid">15231910</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Lorenzo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Colletti</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Boyle</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Gerson</surname> <given-names>WT</given-names></name>, <name name-style="western"><surname>Hyams</surname> <given-names>JS</given-names></name>, <etal>et al</etal>. <article-title>Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition: AAP Subcommittee and NASPGHAN Committee on Chronic Abdominal Pain</article-title>. <source>J Pediatr Gastroenterol Nutr</source> <year>2005</year>;<volume>40</volume>(<issue>3</issue>):<fpage>249</fpage>–<lpage>261</lpage>. <object-id pub-id-type="pmid">15735476</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rasquin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Di Lorenzo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Forbes</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Guiraldes</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hyams</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Staiano</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Childhood functional gastrointestinal disorders: child/adolescent</article-title>. <source>Gastroenterology</source> <year>2006</year> <month>Apr</month>;<volume>130</volume>(<issue>5</issue>):<fpage>1527</fpage>–<lpage>1537</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2005.08.063" xlink:type="simple">10.1053/j.gastro.2005.08.063</ext-link></comment> <object-id pub-id-type="pmid">16678566</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gieteling</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bierma-Zeinstra</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Passchier</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>MY</given-names></name>. <article-title>Prognosis of chronic or recurrent abdominal pain in children</article-title>. <source>J Pediatr Gastroenterol Nutr</source> <year>2008</year> <month>Sep</month>;<volume>47</volume>(<issue>3</issue>):<fpage>316</fpage>–<lpage>326</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MPG.0b013e31815bc1c1" xlink:type="simple">10.1097/MPG.0b013e31815bc1c1</ext-link></comment> <object-id pub-id-type="pmid">18728528</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Tilburg</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Venepalli</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ulshen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Freeman</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Whitehead</surname> <given-names>WE</given-names></name>. <article-title>Parents’ worries about recurrent abdominal pain in children</article-title>. <source>Gastroenterology Nursing</source> <year>2006</year>;<volume>29</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>55</lpage>. <object-id pub-id-type="pmid">16552300</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Ferry</surname> <given-names>GD</given-names></name>. <article-title>Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations</article-title>. <source>Gastroenterology</source> <year>2004</year> <month>May</month>;<volume>126</volume>(<issue>6</issue>):<fpage>1550</fpage>–<lpage>1560</lpage>. <object-id pub-id-type="pmid">15168366</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levine</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Koletzko</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Escher</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Cucchiara</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>de Ridder</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents</article-title>. <source>J Pediatr Gastroenterol Nutr</source> <year>2014</year> <month>Jun</month>;<volume>58</volume>(<issue>6</issue>):<fpage>795</fpage>–<lpage>806</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MPG.0000000000000239" xlink:type="simple">10.1097/MPG.0000000000000239</ext-link></comment> <object-id pub-id-type="pmid">24231644</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Ridder</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Rings</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Escher</surname> <given-names>JC</given-names></name>, <collab>CBO-werkgroep ‘IBD bij kinderen’</collab>. <article-title>Guideline ‘Diagnosis and treatment of inflammatory bowel disease in children’</article-title>. <source>Ned Tijdschr Geneeskd</source> <year>2010</year>;<volume>154</volume>:<fpage>A1898</fpage>.</mixed-citation></ref>
<ref id="pone.0189111.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holtman</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Lisman-van Leeuwen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>MY</given-names></name>. <article-title>Noninvasive Tests for Inflammatory Bowel Disease: A Meta-analysis</article-title>. <source>Pediatrics</source> <year>2016</year> <month>Jan</month>;<volume>137</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="pone.0189111.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vermeire</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Van Assche</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rutgeerts</surname> <given-names>P</given-names></name>. <article-title>Laboratory markers in IBD: useful, magic, or unnecessary toys?</article-title> <source>Gut</source> <year>2006</year> <month>Mar</month>;<volume>55</volume>(<issue>3</issue>):<fpage>426</fpage>–<lpage>431</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/gut.2005.069476" xlink:type="simple">10.1136/gut.2005.069476</ext-link></comment> <object-id pub-id-type="pmid">16474109</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holtman</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Lisman-van Leeuwen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kollen</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Norbruis</surname> <given-names>OF</given-names></name>, <name name-style="western"><surname>Escher</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Kindermann</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study</article-title>. <source>Ann Fam Med</source> <year>2016</year> <month>Sep</month>;<volume>14</volume>(<issue>5</issue>):<fpage>437</fpage>–<lpage>445</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1370/afm.1949" xlink:type="simple">10.1370/afm.1949</ext-link></comment> <object-id pub-id-type="pmid">27621160</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vickers</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Van Calster</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Steyerberg</surname> <given-names>EW</given-names></name>. <article-title>Net benefit approaches to the evaluation of prediction models, molecular markers and diagnostic tests</article-title>. <source>BMJ-British Medical Journal</source> <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0189111.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holtman</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Lisman-van Leeuwen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kollen</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Escher</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Kindermann</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rheenen</surname> <given-names>PF</given-names></name>, <etal>et al</etal>. <article-title>Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example</article-title>. <source>BMC Fam Pract</source> <year>2013</year> <month>Nov</month> <day>25</day>;<volume>14</volume>:<fpage>179</fpage>-2296-14-179. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2296-14-179" xlink:type="simple">10.1186/1471-2296-14-179</ext-link></comment> <object-id pub-id-type="pmid">24274463</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewis</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Heaton</surname> <given-names>KW</given-names></name>. <article-title>Stool form scale as a useful guide to intestinal transit time</article-title>. <source>Scand J Gastroenterol</source> <year>1997</year> <month>Sep</month>;<volume>32</volume>(<issue>9</issue>):<fpage>920</fpage>–<lpage>924</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/00365529709011203" xlink:type="simple">10.3109/00365529709011203</ext-link></comment> <object-id pub-id-type="pmid">9299672</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oord</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hornung</surname> <given-names>N</given-names></name>. <article-title>Fecal calprotectin in healthy children</article-title>. <source>Scand J Clin Lab Invest</source> <year>2014</year> /;<volume>74</volume>(<issue>3</issue>):<fpage>254</fpage>–<lpage>258</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/00365513.2013.879732" xlink:type="simple">10.3109/00365513.2013.879732</ext-link></comment> <object-id pub-id-type="pmid">24568692</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gisbert</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>McNicholl</surname> <given-names>A</given-names></name>. <article-title>Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease</article-title>. <source>Digestive and Liver Disease</source> <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>56</fpage>–<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dld.2008.05.008" xlink:type="simple">10.1016/j.dld.2008.05.008</ext-link></comment> <object-id pub-id-type="pmid">18602356</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pels</surname> <given-names>LP</given-names></name>, <name name-style="western"><surname>Van de Vijver</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Waalkens</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Uitentuis</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>JGonera-de ong</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>van Overbeek</surname> <given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management"</article-title>. <source>J Pediatr Gastroenterol Nutr</source> <year>2010</year> <month>Dec</month>;<volume>51</volume>(<issue>6</issue>):<fpage>708</fpage>–<lpage>713</lpage>.</mixed-citation></ref>
<ref id="pone.0189111.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van de Vijver</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Schreuder</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Cnossen</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Muller Kobold</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>van Rheenen</surname> <given-names>PF</given-names></name>, <collab>North Netherlands Pediatric IBD Consortium</collab>. <article-title>Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy</article-title>. <source>Arch Dis Child</source> <year>2012</year> <month>Dec</month>;<volume>97</volume>(<issue>12</issue>):<fpage>1014</fpage>–<lpage>1018</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/archdischild-2011-301206" xlink:type="simple">10.1136/archdischild-2011-301206</ext-link></comment> <object-id pub-id-type="pmid">23019289</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mack</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Langton</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Markowitz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>LeLeiko</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Griffiths</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bousvaros</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Laboratory values for children with newly diagnosed inflammatory bowel disease</article-title>. <source>Pediatrics</source> <year>2007</year> <month>Jun</month>;<volume>119</volume>(<issue>6</issue>):<fpage>1113</fpage>–<lpage>1119</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1542/peds.2006-1865" xlink:type="simple">10.1542/peds.2006-1865</ext-link></comment> <object-id pub-id-type="pmid">17545378</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vittinghoff</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>McCulloch</surname> <given-names>CE</given-names></name>. <article-title>Relaxing the rule of ten events per variable in logistic and Cox regression</article-title>. <source>Am J Epidemiol</source> <year>2007</year> <month>Mar</month> <day>15</day>;<volume>165</volume>(<issue>6</issue>):<fpage>710</fpage>–<lpage>718</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwk052" xlink:type="simple">10.1093/aje/kwk052</ext-link></comment> <object-id pub-id-type="pmid">17182981</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peduzzi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Concato</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kemper</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Holford</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Feinstein</surname> <given-names>AR</given-names></name>. <article-title>A simulation study of the number of events per variable in logistic regression analysis</article-title>. <source>J Clin Epidemiol</source> <year>1996</year>;<volume>49</volume>(<issue>12</issue>):<fpage>1373</fpage>–<lpage>1379</lpage>. <object-id pub-id-type="pmid">8970487</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLong</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>DeLong</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Clarke-Pearson</surname> <given-names>DL</given-names></name>. <article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</article-title>. <source>Biometrics</source> <year>1988</year>:<fpage>837</fpage>–<lpage>845</lpage>. <object-id pub-id-type="pmid">3203132</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vickers</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Elkin</surname> <given-names>EB</given-names></name>. <article-title>Decision curve analysis: a novel method for evaluating prediction models</article-title>. <source>Med Decis Making</source> <year>2006</year> <month>Nov-Dec</month>;<volume>26</volume>(<issue>6</issue>):<fpage>565</fpage>–<lpage>574</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0272989X06295361" xlink:type="simple">10.1177/0272989X06295361</ext-link></comment> <object-id pub-id-type="pmid">17099194</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>de Groot</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Linnet</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Bossuyt</surname> <given-names>PM</given-names></name>. <article-title>Quantifying the added value of a diagnostic test or marker</article-title>. <source>Clin Chem</source> <year>2012</year> <month>Oct</month>;<volume>58</volume>(<issue>10</issue>):<fpage>1408</fpage>–<lpage>1417</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1373/clinchem.2012.182550" xlink:type="simple">10.1373/clinchem.2012.182550</ext-link></comment> <object-id pub-id-type="pmid">22952348</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steyerberg</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Vickers</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Gerds</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gonen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Obuchowski</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Assessing the performance of prediction models: a framework for traditional and novel measures</article-title>. <source>Epidemiology</source> <year>2010</year> <month>Jan</month>;<volume>21</volume>(<issue>1</issue>):<fpage>128</fpage>–<lpage>138</lpage>.</mixed-citation></ref>
<ref id="pone.0189111.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van der Heijden</surname> <given-names>Geert JMG</given-names></name>, <name name-style="western"><surname>Donders</surname> <given-names>ART</given-names></name>, <name name-style="western"><surname>Stijnen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>. <article-title>Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example</article-title>. <source>J Clin Epidemiol</source> <year>2006</year>;<volume>59</volume>(<issue>10</issue>):<fpage>1102</fpage>–<lpage>1109</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jclinepi.2006.01.015" xlink:type="simple">10.1016/j.jclinepi.2006.01.015</ext-link></comment> <object-id pub-id-type="pmid">16980151</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vink</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Frank</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Pannekoek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Buuren</surname> <given-names>S</given-names></name>. <article-title>Predictive mean matching imputation of semicontinuous variables</article-title>. <source>Statistica Neerlandica</source> <year>2014</year>;<volume>68</volume>(<issue>1</issue>):<fpage>61</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="pone.0189111.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Donders</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Stijnen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Harrell</surname> <given-names>FE</given-names></name>. <article-title>Using the outcome for imputation of missing predictor values was preferred</article-title>. <source>J Clin Epidemiol</source> <year>2006</year>;<volume>59</volume>(<issue>10</issue>):<fpage>1092</fpage>–<lpage>1101</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jclinepi.2006.01.009" xlink:type="simple">10.1016/j.jclinepi.2006.01.009</ext-link></comment> <object-id pub-id-type="pmid">16980150</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marshall</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Holder</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Royston</surname> <given-names>P</given-names></name>. <article-title>Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines</article-title>. <source>BMC Med Res Methodol</source> <year>2009</year> <month>Jul</month> <day>28</day>;<volume>9</volume>:<fpage>57</fpage>-2288-9-57. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2288-9-57" xlink:type="simple">10.1186/1471-2288-9-57</ext-link></comment> <object-id pub-id-type="pmid">19638200</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Degraeuwe</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Beld</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Ashorn</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Canani</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Day</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Diamanti</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Faecal calprotectin in suspected paediatric inflammatory bowel disease</article-title>. <source>J Pediatr Gastroenterol Nutr</source> <year>2015</year> <month>Mar</month>;<volume>60</volume>(<issue>3</issue>):<fpage>339</fpage>–<lpage>346</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MPG.0000000000000615" xlink:type="simple">10.1097/MPG.0000000000000615</ext-link></comment> <object-id pub-id-type="pmid">25373864</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref036"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Thomson S, Osborn R, Squires D, Reed SJ. International profiles of health care systems 2011: Australia, Canada, Denmark, England, France, Germany, Iceland, Italy, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States. 2011.</mixed-citation></ref>
<ref id="pone.0189111.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oostenbrink</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Bleeker</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Moll</surname> <given-names>HA</given-names></name>, <name name-style="western"><surname>Grobbee</surname> <given-names>DE</given-names></name>. <article-title>Diagnostic research on routine care data: prospects and problems</article-title>. <source>J Clin Epidemiol</source> <year>2003</year>;<volume>56</volume>(<issue>6</issue>):<fpage>501</fpage>–<lpage>506</lpage>. <object-id pub-id-type="pmid">12873643</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naaktgeboren</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>De Groot</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>van Smeden</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>. <article-title>Evaluating diagnostic accuracy in the face of multiple reference standards</article-title>. <source>Ann Intern Med</source> <year>2013</year>;<volume>159</volume>(<issue>3</issue>):<fpage>195</fpage>–<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7326/0003-4819-159-3-201308060-00009" xlink:type="simple">10.7326/0003-4819-159-3-201308060-00009</ext-link></comment> <object-id pub-id-type="pmid">23922065</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naaktgeboren</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>de Groot</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Rutjes</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Bossuyt</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Moons</surname> <given-names>KG</given-names></name>. <article-title>Anticipating missing reference standard data when planning diagnostic accuracy studies</article-title>. <source>BMJ</source> <year>2016</year> <month>Feb</month> <day>9</day>;<volume>352</volume>:<fpage>i402</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.i402" xlink:type="simple">10.1136/bmj.i402</ext-link></comment> <object-id pub-id-type="pmid">26861453</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knottnerus</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Dinant</surname> <given-names>GJ</given-names></name>. <article-title>Medicine based evidence, a prerequisite for evidence based medicine</article-title>. <source>BMJ</source> <year>1997</year> <month>Nov</month> <day>1</day>;<volume>315</volume>(<issue>7116</issue>):<fpage>1109</fpage>–<lpage>1110</lpage>. <object-id pub-id-type="pmid">9374881</object-id></mixed-citation></ref>
<ref id="pone.0189111.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gieteling</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Van Dijk</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>De Jonge</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Albeda</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>J</given-names></name>. <article-title>NHG-Standaard Buikpijn bij kinderen</article-title>. <source>Huisarts Wet</source> <year>2012</year>;<volume>55</volume>:<fpage>404</fpage>–<lpage>409</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>